New

Stem Cell Therapy Market

2021

Stem Cell Therapy Market to 2027 - Global Analysis and Forecast by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Other Stem Cell Therapy); Treatment (Allogeneic, Autologous ); Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery and Development, Other Applications); End User (Hospitals and Specialty Clinics, Academic and Research Institutes), and Geography

Publication Month: Mar 2020 | Report Code: TIPHE100000991 | No. of Pages: 183 | Category: Biotechnology | Status: Published

Market Insights

Stem Cell Therapy Market to Grow at a CAGR of 16.7% to reach US$ 5,129.66 million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Stem Cell Therapy in healthcare market was valued at US$ 1,534.55 million in 2019 and it is projected to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.

Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryo, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated. The growth of the Stem Cell Therapy in healthcare market is attributed to the increasing prevalence of chronic conditions and increasing demand for regenerative medicines. However, high cost associated with the stem cell therapies is expected to hamper the growth of the market during the forecast years.

The Stem Cell Therapy in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Stem Cell Therapy in Healthcare Market
Lucrative Regions for Stem Cell Therapy in Healthcare Market

Get more information on this report :


Market Insights

Growing Applications of Stem Cell Therapy in Healthcare to Drive Stem Cell Therapy in Healthcare Market Growth

Stem cell research has been widely investigated globally to enhance human health in a medical setting. For this, creating public awareness about stem cell research is vital for realizing this potential. The stem cell's main role is to replace dying cells and reconstruct damaged tissues. Based on the extensive stem cell research results, many scientists have claimed that the cells could probably generate cures and treatment for various diseases, including cancers, cardiovascular disease, and others. Newly developed stem cell therapies having the capability to replace disease, causing cells. Hence, patients now started relying on stem cell therapy that has long term positive outcomes. There is an increasing number of potential treatments that are undergoing in clinical trials phase. The FDA has approved very few stem cell therapies. For instance, in 2019, Fedratinib, approved by the FDA for the first-line treatment for myelofibrosis. Bone marrow transplantation is widely used stem cell based therapy. Blood forming stem cells were the first to be used in the clinic. This stem cell therapy has benefited thousands of patients who have leukemia.

Researchers are further investigating stem cell therapy in autoimmune disorder. Other adult stem cells based treatments are under clinical trials. Hematopoietic stem cells are currently used for treating more than 80 medical diseases, which include diseases of the immune system, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and several types of cancers like leukemia, lymphoma, etc.

Regenerative medicine uses cells, biomaterials, and molecules to fix structures in the body that does not function correctly due to disease or impairment. Academic institutions are starting the centers for research, particularly for regenerative medicines. For instance, in 2018, the University of Florida launched a new Center for Regenerative Medicine to develop lifesaving therapies using stem cells that repair damaged tissue and organs. In 2018, the U.S. Food and Drug Administration (FDA) approved Mayo Clinic to automate the stem cell production for clinical trials.

Growing demand for regenerative medicine has the opportunity for manufacturers to enter into research activity. For instance, in 2019, EmCyte Corporation launched the not for profit and independent regenerative medicine scientific and educational institute named as The Gulf Coast Biologics Training Center. The aim of the center is to establish and standardize evidence-based clinically scientific treatment methodology and to educate and train practitioners on the best use and application of regenerative autologous biologics.

Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.

Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer. These statistics determine an increase in the demand for advanced cancer diagnostics in various regions across the globe. Hence, driving the growth of stem cell therapy market during the forecast period.

Type-Based Insights

In terms of type, the Stem Cell Therapy in healthcare market is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. In 2019 adult stem cell therapy held the largest share of the market.

Stem Cell Therapy in Healthcare Market, by Type – 2019 and 2027
Stem Cell Therapy in Healthcare Market, by Type – 2019 and 2027

Get more information on this report :



Treatment-Based Insights

Based on treatment, the Stem Cell Therapy in healthcare market is segmented into allogeneic and autologous. The allogeneic held the largest share of disease segment in the global market. However, autologous segment is expected to grow at the faster rate during the forecast period. Factors contributing in the growth of autologous market are low risk associated, affordable treatment and no risk of graft versus host diseases.

Application-Based Insights

Based on application, the Stem Cell Therapy in healthcare market is segmented into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The prophylaxis held the largest share of the stem cell therapy market for the treatment type segment. However, the drug discovery and development segment is expected to grow at the fastest rate during the coming years.

End User-Based Insights

In terms of end user, the Stem Cell Therapy in healthcare market is segmented into academic and research institutes, hospitals and specialty clinics. The academic and research institutes held the largest share of end user segment in the global market and is expected to grow at the fastest rate during the forecast period.

Strategic Insights

The Stem Cell Therapy in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Stem Cell Therapy in Healthcare Market – by Type

  • Adult Stem Cell Therapy
  • Embryonic Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Other Stem Cell Therapy

Stem Cell Therapy in Healthcare Market – by Treatment

  • Allogeneic
  • Autologous

Stem Cell Therapy in Healthcare Market – by Application

  • Musculoskeletal
  • Dermatology
  • Cardiology
  • Drug Discovery and Development
  • Other Applications

Stem Cell Therapy in Healthcare Market – by End User

  • Hospitals and Specialty Clinics
  • Academic and Research Institutes

Stem Cell Therapy in Healthcare Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Medipost
  • pharmicell Co., Ltd.
  • Holostem Terapie Avanzate S.R.L.
  • Mesoblast Ltd.
  • U.S. Stem Cell, Inc.
  • Biotime, Inc.
  • RichSource
  • Caladrius
  • TiGenix NV (Takeda Pharmaceuticals)
  • Genea Biocells

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Stem Cell Therapy Market – By Type

1.3.2 Global Stem Cell Therapy Market – By Treatment

1.3.3 Global Stem Cell Therapy Market – By Application

1.3.4 Global Stem Cell Therapy Market – By End User

1.3.5 Global Stem Cell Therapy Market – By Geography

2. Stem Cell Therapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Stem Cell Therapy – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America

4.2.2 Europe

4.2.3 Asia Pacific

4.2.4 Middle East & Africa

4.2.5 South and Central America

4.3 Expert Opinion

5. Stem Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management

5.1.2 Growing Demand For Regenerative Medicines

5.1.3 Growing Cancer Prevalence Across The Globe

5.2 Market Restraints

5.2.1 High Cost Related with Stem Cell Therapy

5.3 Market Opportunities

5.3.1 Growth in the Global Healthcare Market

5.4 Future Trends

5.4.1 Research Activities and Product Innovations

5.5 Impact Analysis

6. Stem Cell Therapy Market – Global Analysis

6.1 Global Stem Cell Therapy Market Revenue Forecast And Analysis

6.2 Global Stem Cell Therapy Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. Global Stem Cell Therapy Market Analysis– by Type

7.1 Overview

7.2 Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027)

7.3 Adult Stem Cell Therapy

7.3.1 Overview

7.3.2 Adult Stem Cell Therapy : Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3 Hematopoietic Stem Cell Therapy

7.3.3.1 Overview

7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.3.4 Umbilical Cord Stem Cell Therapy

7.3.4.1 Overview

7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5 Neuronal Stem Cell Therapy

7.3.5.1 Overview

7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6 Mesenchymal Stem Cell

7.3.6.1 Overview

7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Induced Pluripotent Stem Cell Therapy

7.4.1 Overview

7.4.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Embryonic Stem Cell Therapy

7.5.1 Overview

7.5.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Other Stem Cell Therapy

7.6.1 Overview

7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

8. Stem Cell Therapy Market Analysis– by Treatment

8.1 Overview

8.2 Stem Cell Therapy Market, by Treatment 2019 and 2027 (%)

8.3 Allogeneic

8.3.1 Overview

8.3.2 Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Autologous

8.4.1 Overview

8.4.2 Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9. Stem Cell Therapy Market Analysis – by Application

9.1 Overview

9.2 Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027)

9.3 Musculoskeletal

9.3.1 Overview

9.3.2 Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Dermatology

9.4.1 Overview

9.4.2 Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Cardiology

9.5.1 Overview

9.5.2 Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.6 Drug Discovery and Development

9.6.1 Overview

9.6.2 Drug Discovery and Development: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.7 Other Applications

9.7.1 Overview

9.7.2 Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10. Stem Cell Therapy Market Analysis– by End User

10.1 Overview

10.2 Stem Cell Therapy Market, by End User 2019 and 2027 (%)

10.3 Academic & Research Institutes

10.3.1 Overview

10.3.2 Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10.4 Hospitals & Specialty Clinics

10.4.1 Overview

10.4.2 Hospitals & Specialty Clinics : Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11. Stem Cell Therapy Market – Geographic Analysis

11.1 North America: Stem Cell Therapy Market

11.1.1 Overview

11.1.2 North America: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.3 North America: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.1.3.1 North America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.1.4 North America: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.1.5 North America: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.1.6 North America: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.1.7 North America: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

11.1.8 US: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 US: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 US: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.1.8.2.1 US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.1.8.3 US: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.1.8.4 US: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.1.8.5 US: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.1.9 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 Canada: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.1.9.2.1 Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.1.9.3 Canada: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.1.9.4 Canada: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.1.9.5 Canada: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.1.10 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.1.10.2.1 Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.1.10.3 Mexico: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.1.10.4 Mexico: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.1.10.5 Mexico: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2 Europe: Stem Cell Therapy Market

11.2.1 Overview

11.2.2 Europe: Stem Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)

11.2.3 Europe: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.3.1 Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.4 Europe: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.5 Europe: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.6 Europe: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2.7 Europe: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

11.2.8 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.1 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.2 Germany: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.8.2.1 Germany: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.8.3 Germany: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.8.4 Germany: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.8.5 Germany: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2.9 UK: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.1 UK: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.2 United Kingdom: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.9.2.1 United Kingdom: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.9.3 United Kingdom: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.9.4 United Kingdom: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.9.5 United Kingdom: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2.10 France: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.1 France: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.2 France: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.10.2.1 France: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.10.3 France: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.10.4 France: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.10.5 France: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2.11 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.1 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.2 Spain: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.11.2.1 Spain: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.11.3 Spain: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.11.4 Spain: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.11.5 Spain: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.2.12 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.1 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.2 Italy: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.2.12.2.1 Italy: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.2.12.3 Italy: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.2.12.4 Italy: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.2.12.5 Italy: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3 Asia Pacific: Stem Cell Therapy Market

11.3.1 Overview

11.3.2 Asia Pacific: Stem Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)

11.3.3 Asia Pacific: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.3.1 Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.4 Asia Pacific: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.5 Asia Pacific: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.6 Asia Pacific: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3.7 Asia Pacific: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

11.3.8 China: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.1 China: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.2 China: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.8.2.1 China: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.8.3 China: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.8.4 China: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.8.5 China: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3.9 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.1 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.2 Japan: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.9.2.1 Japan: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.9.3 Japan: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.9.4 Japan: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.9.5 Japan: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3.10 India: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.1 India: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.2 India: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.10.2.1 India: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.10.3 India: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.10.4 India: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.10.5 India: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3.11 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.1 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.2 South Korea: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.11.2.1 South Korea: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.11.3 South Korea: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.11.4 South Korea: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.11.5 South Korea: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.3.12 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.1 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.2 Australia: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.3.12.2.1 Australia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.3.12.3 Australia: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.3.12.4 Australia: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.3.12.5 Australia: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.4 Middle East & Africa: Stem Cell Therapy Market

11.4.1 Overview

11.4.2 Middle East & Africa: Stem Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)

11.4.3 Middle East & Africa: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.4.3.1 Middle East & Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.4.4 Middle East & Africa: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.4.5 Middle East & Africa: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.4.6 Middle East & Africa: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.4.7 Middle East & Africa: Stem Cell Therapy Market Share by Country – 2019 & 2027, (%)

11.4.8 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.2 Saudi Arabia: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.4.8.2.1 Saudi Arabia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.4.8.3 Saudi Arabia: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.4.8.4 Saudi Arabia: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.4.8.5 Saudi Arabia: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.4.9 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.1 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.2 UAE: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.4.9.2.1 UAE: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.4.9.3 UAE: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.4.9.4 UAE: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.4.9.5 UAE: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.4.10 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.4.10.1 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.4.10.2 South Africa: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.4.10.2.1 South Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.4.10.3 South Africa: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.4.10.4 South Africa: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.4.10.5 South Africa: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.5 South and Central America: Stem Cell Therapy Market

11.5.1 Overview

11.5.2 South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11.5.3 South and Central America: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.5.3.1 South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.5.4 South and Central America: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.5.5 South and Central America: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.5.6 South and Central America: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.5.7 South and Central America: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

11.5.8 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.1 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.2 Brazil: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.5.8.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.5.8.3 Brazil: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.5.8.4 Brazil: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.5.8.5 Brazil: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

11.5.9 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.1 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.2 Argentina: Stem Cell Therapy Market, by Type, 2018–2027 (USD Million)

11.5.9.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2018–2027 (USD Million)

11.5.9.3 Argentina: Stem Cell Therapy Market, by Treatment, 2018–2027 (USD Million)

11.5.9.4 Argentina: Stem Cell Therapy Market, by Application, 2018–2027 (USD Million)

11.5.9.5 Argentina: Stem Cell Therapy Market, by End User , 2018–2027 (USD Million)

12. Stem Cell Therapy Market –Industry Landscape

12.1 Overview

12.2 Growth Strategies In The Stem Cell Therapy Market, 2015-2019

12.3 Organic Growth Strategies

12.3.1 Overview

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. COMPANY PROFILES

13.1 MEDIPOST

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Pharmicell Co., Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 RichSource

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 BioTime Inc. (Lineage Cell Therapeutics, Inc.)

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Mesoblast Limited

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Holostem Terapie Avanzate Srl

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 U.S. Stem Cell, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Caladrius Biosciences, Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 TiGenix NV

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 AlloSource

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

LIST OF TABLES

Table 1. North America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2. North America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 3. North America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4. North America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5. North America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 6. US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7. US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 8. US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9. US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10. US Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 13. Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14. Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. Canada Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17. Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 18. Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 19. Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20. Mexico Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 21. Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 22. Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 23. Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 24. Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25. Europe Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 26. Germany Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27. Germany Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 28. Germany Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 29. Germany Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 30. Germany Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 31. United Kingdom Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32. United Kingdom Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 33. United Kingdom Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 34. United Kingdom Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 35. United Kingdom Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 36. France Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 37. France Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 38. France Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 39. France Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 40. France Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 41. Spain Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 42. Spain Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 43. Spain Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 44. Spain Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 45. Spain Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 46. Italy Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 47. Italy Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 48. Italy Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 49. Italy Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 50. Italy Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 51. Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 52. Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 53. Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 54. Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 55. Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 56. China Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 57. China Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 58. China Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 59. China Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 60. China Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 61. Japan Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 62. Japan Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 63. Japan Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 64. Japan Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 65. Japan Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 66. India Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 67. India Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 68. India Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 69. India Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 70. India Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 71. South Korea Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 72. South Korea Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 73. South Korea Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 74. South Korea Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 75. South Korea Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 76. Australia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 77. Australia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 78. Australia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 79. Australia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 80. Australia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 81. Middle East & Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 82. Middle East & Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 83. Middle East & Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 84. Middle East & Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 85. Middle East & Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 86. Saudi Arabia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 87. Saudi Arabia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 88. Saudi Arabia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 89. Saudi Arabia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 90. Saudi Arabia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 91. UAE Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 92. UAE Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 93. UAE Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 94. UAE Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 95. UAE Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 96. South Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 97. South Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 98. South Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 99. South Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 100. South Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 101. South and Central America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 102. South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 103. South and Central America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 104. South and Central America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 105. South and Central America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 106. Brazil Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 107. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 108. Brazil Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 109. Brazil Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 110. Brazil Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 111. Argentina Stem Cell Therapy Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 112. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2027 (USD Million)

Table 113. Argentina Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 114. Argentina Stem Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 115. Argentina Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)

Table 116. Recent Organic Growth Strategies in the Stem Cell Therapy market

Table 117. Recent Inorganic Growth Strategies In The Stem Cell Therapy Market

LIST OF FIGURES

Figure 1. Stem Cell Therapy Market Segmentation

Figure 2. Stem Cell Therapy Segmentation, By Region

Figure 3. Global Stem Cell Therapy Market Overview

Figure 4. Adult Stem Cell Therapy Segment Held Largest Share Of Type Segment In Stem Cell Therapy Market

Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Global Stem Cell Therapy Market, By Geography (US$ Million)

Figure 7. Global Stem Cell Therapy Market- Leading Country Markets (US$ Million)

Figure 8. North America PEST Analysis

Figure 9. Europe: PEST Analysis

Figure 10. Asia Pacific PEST Analysis

Figure 11. Middle East & Africa PEST Analysis

Figure 12. South and Central America PEST Analysis

Figure 13. Most Prevalent Forms of Cancers Globally, 2018

Figure 14. Stem Cell Therapy Market Impact Analysis of Drivers and Restraints

Figure 15. Global Stem Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16. Global Stem Cell Therapy Market – By Geography Forecast And Analysis – 2019- 2027

Figure 17. Market Positioning Of Key Players In Global Stem Cell Therapy Market

Figure 18. Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027)

Figure 19. Adult Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24. Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25. Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Global Stem Cell Therapy Market, by Treatment 2019 and 2027 (%)

Figure 27. Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28. Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29. Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027)

Figure 30. Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31. Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32. Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33. Drug Discovery and Development : Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34. Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35. Global Stem Cell Therapy Market, by End User 2019 and 2027 (%)

Figure 36. Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37. Hospitals & Specialty Clinics: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 38. North America: Stem Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 39. North America Stem Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 40. North America: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

Figure 41. US: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 42. Canada: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 43. Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 44. Europe: Stem Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 45. Europe Stem Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 46. Europe: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

Figure 47. Germany: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 48. UK: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 49. France: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 50. Spain: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 51. Italy: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 52. Asia Pacific: Stem Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 53. Asia Pacific Stem Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 54. China: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 55. Japan: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 56. India: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 57. South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 58. Australia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 59. Middle East & Africa: Stem Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 60. Middle East & Africa Stem Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 61. Middle East & Africa: Stem Cell Therapy Market Share by Country – 2019 & 2027, (%)

Figure 62. Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 63. UAE: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 64. South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 65. South and Central America: Stem Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 66. South and Central America Stem Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 67. South and Central America: Stem Cell Therapy Market, by Country, 2019 & 2027 (%)

Figure 68. Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 69. Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 70. Growth Strategies In The Stem Cell Therapy Market, 2015-2019

The List of Companies – Global Stem Cell Therapy Market

  1. Medipost, pharmicell Co., Ltd.
  2. HolostemTerapieAvanzate S.R.L.
  3. Mesoblast Ltd.
  4. U.S. Stem Cell, Inc.
  5. Biotime, Inc.
  6. RichSource
  7. Caladrius
  8. TiGenix NV (Takeda Pharmaceuticals)
  9. GeneaBiocells
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Stem Cell Therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Stem Cell Therapymarket, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPHE100000991
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.